Lab
Labca INC
Labca INC was paid $441K by Medicaid between Jan 2018 and Dec 2024, across 31 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 15% of everything it billed.
33Billing provider infoLABCA INC
TOA BAJA, PR 00951
TOA BAJA, PR 00951
33aNPI1568511657assigned 01/09/2007
33bProvider typeClinical Medical Laboratory
28Total paid$441K
24GClaims37,100
24DCodes billed31
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#286 of 777
Median peer was paid$278K
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,047 | $33K | |
| 2019 | 3,366 | $32K | |
| 2020 | 4,112 | $42K | |
| 2021 | 7,961 | $105K | |
| 2022 | 5,867 | $88K | |
| 2023 | 5,895 | $72K | |
| 2024incomplete | 5,852 | $68K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 15% | 4,043 | 3,834 | $66K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 13% | 1,326 | 1,223 | $56K |
| 80061 | Lipid panel | 12% | 4,054 | 3,853 | $53K |
| 80053 | Comprehensive metabolic panel | 11% | 4,636 | 4,371 | $47K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 9.7% | 5,625 | 5,245 | $43K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 8.2% | 1,493 | 1,364 | $36K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5.6% | 866 | 814 | $24K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.7% | 2,150 | 2,053 | $21K |
| 81000 | 3.4% | 4,876 | 4,600 | $15K | |
| 82274 | 3.1% | 882 | 826 | $14K | |
| 86701 | 2.1% | 1,016 | 967 | $9K | |
| 86328 | 1.5% | 384 | 368 | $7K |
19 more codes
| 84436 | 1.3% | 807 | $6K | |
| 82043 | 1.3% | 937 | $6K | |
| 84479 | 1.2% | 805 | $5K | |
| 36415 | Collection of venous blood by venipuncture | 1.2% | 618 | $5K |
| 84153 | 1.1% | 261 | $5K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 358 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 80 | $3K |
| 86738 | <1% | 171 | $3K | |
| 87088 | <1% | 277 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 51 | $2K |
| 86329 | <1% | 158 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 265 | $2K |
| 86592 | <1% | 345 | $1K | |
| 84439 | <1% | 119 | $1K | |
| 82607 | <1% | 72 | $1K | |
| 82570 | <1% | 73 | $401.06 | |
| 86803 | <1% | 26 | $395.35 | |
| 87185 | <1% | 67 | $347.06 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 259 | $0.18 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMARRERO, MIGDALIA (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Labca INC | Manati, PR | $406K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.